以间歇性氧尿素疗法回归后基本血栓细胞血症髓纤维化:一个病例报告
Arumugam Manoharan1, Ian Tang2
1Southern Sydney Haematology, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2500, Australia.
Journal of clinical medicine
|December 30, 2025
概括
间歇性氧尿素疗法有效控制了后必需血小板血,骨髓纤维化和骨髓纤维化. 这种方法对髓增殖性瘤,包括氧尿素耐药病例有希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基本血小板血可以发展为骨髓纤维化.
- 骨髓纤维化是由骨髓痕的特征.
- 氧尿素是骨髓增殖性瘤的标准治疗方法.
研究的目的:
- 报告一种以间歇性氧尿素治疗的后必要性血栓塞瘤骨髓纤维化病例.
- 评估间歇性氧尿素在骨髓增殖性瘤中的疗效.
- 讨论使用间歇性氧尿素在氧尿素耐药或不耐受患者的理由.
主要方法:
- 一名患有后基本血小板血栓塞瘤骨髓纤维化症的患者接受间歇性氧尿素 (20 mg/kg,每周三次).
- 评估了疾病控制和骨髓纤维化回归.
- 这项研究讨论了间歇性氧尿素在骨髓增殖性瘤中的使用.
主要成果:
- 在患者身上实现了持续的疾病控制.
- 观察到骨髓纤维化的显著回归.
- 间歇性氧尿素在治疗骨髓增殖性瘤方面表现出有效性.
结论:
- 间歇性氧尿素疗法是有效的管理后必要的血小板血 myelofibrosis.
- 这种剂量表为骨髓增殖性瘤提供了一种可行的治疗选择.
- 间歇性氧尿素可能有利于耐药或不耐持续治疗的患者.
相关概念视频
Venous Thrombosis III: Interprofessional Care
257
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
Hemodialysis II: Procedure and Complications
558
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
558
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
162
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
162
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
173
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
173
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
418
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
418


